Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glulisine vs Lispro in Gestational Diabetes
NCT01662921Phase 2Completed
- Sponsor
- Sansum Diabetes Research Institute
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of insulin glulisine in gestational diabetes mellitus (GDM), sponsored by Sansum Diabetes Research Institute. Started Apr 2013; status: completed.
02
Drugs
insulin glulisine
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT01662921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662921.